Pune, India -- (SBWire) -- 06/24/2019 --The Global Granulomatosis with Polyangiitis Diagnosis Market is likely to gain from the introduction of new diagnosis procedure. Fortune Business Insights has recently announced a report, titled "Granulomatosis with Polyangiitis Diagnosis Market Size, Share and Global Trend by Treatment (Blood Tests, Urinalysis, Imaging Tests, Biopsy), By End-User (Hospitals, Clinics, Diagnostic Centers), and Geography Forecast 8till 2026."
Request Sample PDF:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/granulomatosis-with-polyangiitis-diagnosis-market-100182
As per the National Institutes of Health (NIH), in the U.S. approximately every 3rd person in 1,00,000 is effected with Granulomatosis with Polyangiitis. The increasing cases of the diseases are expected to fuel the demand for granulomatosis with polyangiitis treatment and therapeutics. The report offers a comprehensive overview of the global Granulomatosis With Polyangiitis Diagnosis Market.
North America held a considerable share in the market in 2018. The region is also anticipated to witness impressive growth during the forecast period 2019-2026. High prevalence of Granulomatosis with Polyangiitis disorder in the region is expected to contribute towards the market expansion. Europe also enjoys a stronghold in the global market. Availability of highly advanced diagnosis procedure in the region is expected to contribute towards market growth.
The market in the Asia Pacific is likely to witness considerable expansion during the forecast period. In the market Japan is foreseen to offer major expansion opportunities, despite low prevalence of Granulomatosis with Polyangiitis disorder. Owing to the presence and the increasing adoption of hi-tech diagnostic systems, Japan is anticipated to witness impressive growth. Moreover, Japan has highest concentration of medical resonance imaging system, compared to other nations among the Organization for Economic Co-operation and Development. This in response is expected to propel growth in the market.
Introduction of Advance Diagnosis System to Enable Growth in Market
Moreover, the availability of advanced diagnosis systems such as chest x-ray system and MRI computed tomography is a factor likely to fuel the demand in the market. However, the high cost associated with Granulomatosis with Polyangiitis diagnosis may restrain the market.
The Food and Drug Administration approved the first 7T MRI system in 2017. The system is designed to capture a detailed picture of the minute structure and facilitate quality diagnosis of Granulomatosis with Polyangiitis. Certain advancements are likely to fuel the demand for granulomatosis with polyangiitis therapeutics and treatment.
Blood Test Segment to Hold Major Share in Market
In terms of diagnosis, the market can be classified as a blood test, urinalysis, imaging test, and others. The blood test segment holds a considerable share in the market. The segment is also expected to witness promising growth. Blood test offers detection of high levels of erythrocyte sedimentation rate and C reactive protein. This is expected to increase the growth in the market.
The global granulomatosis with polyangiitis market is expanding at a robust pace. Existing players are adopting innovative strategies to lead the market. Some players are involved in mergers and acquisitions and some are focusing on a product launch. Some of the key players operating in the global granulomatosis with polyangiitis diagnosis market are Siemens Healthcare GmbH, GE Healthcare, Koninklijke Philips N.V., Canon Inc., Hitachi, Ltd., and Shimadzu Corporation and Fujifilm Corporation.
Get Customization:
https://www.fortunebusinessinsights.com/enquiry/customization/granulomatosis-with-polyangiitis-diagnosis-market-100182
Granulomatosis with Polyangiitis Diagnosis Market Opportunities, Revenue and Growth Rate, Size, Share Forecast Till 2026
Granulomatosis With Polyangiitis Diagnosis Market Historical Analysis, Opportunities and Industry Segments, Rapid Growth by 2026